Bloomberg News

Kamada Gains to Two-Month High on Its 2012 Revenue Forecast

April 01, 2012

Kamada Ltd. (KMDA) rose to the highest level in more than two months after the biopharmaceutical company forecast 257 million shekels ($69 million) revenue for 2012.

The shares advanced 4.7 percent to 22.40 shekels as of 11:17 a.m. in Tel Aviv, the highest intraday level since Jan. 19, giving the Nes Ziona, Israel-based company a market value of 618.6 million shekels.

To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at

To contact the editor responsible for this story: Claudia Maedler at

Toyota's Hydrogen Man
blog comments powered by Disqus